
pmid: 17201094
handle: 11388/44535
Linezolid, an oxazolidinone that acts by inhibiting protein synthesis, was evaluated in strains of tuberculosis and non-tubercular mycobacteria resistant to one or more drugs isolated in northern Sardinia. The in vitro activity of Linezolid (Pfizer) was assessed on different isolates of Mycobacterium spp. from clinical samples by the Proportional Method. Linezolid demonstrated an excellent activity against the 24 strains of M. tuberculosis and against M. gordonae, M. marinum, M. aurum, M. phlei, and M. avium, with MIC values ranging from 0.5 to 2 microg/ml. Linezolid can be used in combination with the standard antitubercular medications, or as an effective therapeutic alternative in infections caused by M. tuberculosis or by other species of non-tubercular mycobacteria.
Linezolid, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Linezolid, M. tuberculosis, non-tubercular mycobacteria, mycobacteria drugs resistant., Mycobacterium, Anti-Infective Agents, Italy, Acetamides, Drug Resistance, Bacterial, Humans, Oxazolidinones
Linezolid, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Linezolid, M. tuberculosis, non-tubercular mycobacteria, mycobacteria drugs resistant., Mycobacterium, Anti-Infective Agents, Italy, Acetamides, Drug Resistance, Bacterial, Humans, Oxazolidinones
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 15 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
